CLAVIS PHARMA AS has a total of 28 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Canada and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are MSD OSS BV, PHARMACIA ITALIA SPA and 4 AZA BIOSCIENCE NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | Taiwan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | New Zealand | 2 | |
#10 | Ukraine | 2 | |
#11 | South Africa | 2 | |
#12 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Steroids | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Myhren Finn | 23 |
#2 | Eriksen Ole Henrik | 20 |
#3 | Sandvold Marit Liland | 13 |
#4 | Hagen Steinar | 13 |
#5 | Liland Sandvold Marit | 8 |
#6 | Finn Myhren | 3 |
#7 | Henrik Eriksen Ole | 3 |
#8 | Eriksen Ole H | 2 |
#9 | Sandvold Marit L | 2 |
#10 | Sayeh Ahrabi | 1 |
Publication | Filing date | Title |
---|---|---|
TW201018470A | Oral formulations of gemcitabine derivatives | |
US2007225248A1 | Oral dosage forms of gemcitabine derivatives | |
KR20070120539A | Oral dosage forms of gemcitabine derivatives | |
US2007135436A1 | Chemical compounds |